IP Library › Granted Patent US 7,928,198
Granted Patent B2
US 7,928,198 · App. 12/174,889 · Granted Apr 19, 2011

IL-B50 polypeptide

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,928,198
App. No.
12/174,889
Granted
Apr 19, 2011
Kind
B2
Abstract

Purified genes encoding cytokines from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.

Claims (5)

1. An isolated polypeptide selected from the group consisting of:

(a) a polypeptide comprising the amino acid sequence of SEQ ID NO:2;

(b) a polypeptide encoded by a nucleic acid molecule having SEQ ID NO:1; and

(c) a polypeptide encoded by a nucleic acid molecule which hybridizes to the complement of the polynucleotide having SEQ ID NO:1 under conditions of about 100 mM salt and in excess of about 55° C., wherein said polypeptide is capable of binding a human IL-B50 receptor.

2. An isolated polypeptide comprising SEQ ID NO:2.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →